Citations (5)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Samar El-Kalyoubi, Mohamed M. Khalifa, Mahmoud T. Abo-Elfadl, Ahmed A. El-Sayed, Ahmed Elkamhawy, Kyeong Lee & Ahmed A. Al-Karmalawy. (2023) Design and synthesis of new spirooxindole candidates and their selenium nanoparticles as potential dual Topo I/II inhibitors, DNA intercalators, and apoptotic inducers. Journal of Enzyme Inhibition and Medicinal Chemistry 38:1.
Read now
Read now
Samar El-Kalyoubi, Samiha A. El-Sebaey, Ahmed A. El-Sayed, Moustafa S. Abdelhamid, Fatimah Agili & Sherin M. Elfeky. (2023) Novel pyrimidine Schiff bases and their selenium-containing nanoparticles as dual inhibitors of CDK1 and tubulin polymerase: design, synthesis, anti-proliferative evaluation, and molecular modelling. Journal of Enzyme Inhibition and Medicinal Chemistry 38:1.
Read now
Read now
Articles from other publishers (3)
Meng Zhou, Tao Jin, Ying Liu, Shuo Wang, Jiankang Feng, Shihe Shao, Chichong Lu & Guofan Jin. (2024) Design, synthesis, cell imaging, and bioactivity assessment of novel Rhodamine-Pyrimidine nido-carborane derivatives as fluorescent anticancer agents. Journal of Molecular Structure 1299, pages 137211.
Crossref
Crossref
Heba A. Elsebaie, Eman A. El-Bastawissy, Kamel M. Elberembally, Eman F. Khaleel, Rehab Mustafa Badi, Moataz A. Shaldam, Wagdy M. Eldehna, Haytham O. Tawfik & Tarek F. El-Moselhy. (2023) Novel 4-(2-arylidenehydrazineyl)thienopyrimidine derivatives as anticancer EGFR inhibitors: Design, synthesis, biological evaluation, kinome selectivity and in silico insights. Bioorganic Chemistry 140, pages 106799.
Crossref
Crossref
Samar El-Kalyoubi, Samiha A. El-Sebaey, Sherin M. Elfeky, Hanan A. AL-Ghulikah & Mona S. El-Zoghbi. (2023) Novel Aminopyrimidine-2,4-diones, 2-Thiopyrimidine-4-ones, and 6-Arylpteridines as Dual-Target Inhibitors of BRD4/PLK1: Design, Synthesis, Cytotoxicity, and Computational Studies. Pharmaceuticals 16:9, pages 1303.
Crossref
Crossref